Icosapent Ethyl

Icosapent Ethyl is a prescription medication primarily used to reduce the risk of cardiovascular events in certain patients. It is an ethyl ester of eicosapentaenoic acid (EPA), an omega-3 fatty acid, and is often prescribed to patients with high triglyceride levels to help lower these levels and reduce the risk of heart attack, stroke, and other cardiovascular issues. The medication is particularly beneficial for individuals with elevated triglycerides who are at risk for cardiovascular diseases.

Icosapent Ethyl was discovered on August 27th 2019 and it currently has a search volume of 33.1K with a growth of +614%.